Investors who Lost Money on Voyager Therapeutics, Inc. Should Contact Levi & Korsinsky about an Ongoing Investigation - VYGR
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Voyager Therapeutics, Inc. (NASDAQ: VYGR) for potential federal securities law violations. This follows Voyager's announcement about assessing alternate payloads for its gene therapy program due to concerns over the siRNA payload component of VY9323.
February 20, 2025 | 12:00 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Voyager Therapeutics is under investigation by Levi & Korsinsky for potential securities law violations. The investigation follows Voyager's decision to reassess its gene therapy program due to concerns about the siRNA payload component of VY9323.
The investigation by Levi & Korsinsky into potential securities law violations is significant for Voyager Therapeutics. The company's recent announcement about issues with its gene therapy program could lead to negative investor sentiment and potential legal consequences, likely impacting the stock price negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100